Filter Results:
(3,381)
Show Results For
- All HBS Web
(3,381)
- People (9)
- News (695)
- Research (2,163)
- Events (34)
- Multimedia (26)
- Faculty Publications (1,256)
Show Results For
- All HBS Web
(3,381)
- People (9)
- News (695)
- Research (2,163)
- Events (34)
- Multimedia (26)
- Faculty Publications (1,256)
- 31 Jul 2018
- Working Paper Summaries
How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants
Keywords: by Alberto Galasso and Hong Luo
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses. View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Biotechnology Industry; Medical Devices and Supplies Industry; Asia; North America; Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7 View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Biotechnology Industry; Medical Devices and Supplies Industry; Asia; North America; Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- 16 Nov 2020
- News
Moderna Announces Promising Vaccine Trial Results
Moderna released promising news on the progress of their coronavirus vaccine this morning, noting that trials showed it to be 94.5% effective. “In this pandemic, what has been awful from a public health standpoint, an economic standpoint, is the worry people have to... View Details
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
Above: photo by Len Rubenstein No disease can be slowed or stopped until it is diagnosed. For diseases with available treatments, the facts are simple: The earlier they are detected, the higher the survival rates. Two companies at the Pagliuca Harvard Life Lab are... View Details
Keywords: Susan Young
- Web
Admissions Resources - Doctoral
letters, and suggestions on how to identify and approach your recommenders. Standardized Tests As you prepare for your PhD application, watch this video to learn more about what standardized tests are... View Details
- 2013
- Article
Planning Prompts as a Means of Increasing Preventive Screening Rates
By: Katherine L Milkman, John Beshears, James J. Choi, David Laibson and Brigitte C. Madrian
Keywords: Reminder Systems; Communication; Economics; Behavioral; Primary Prevention; Colonoscopy; Memory; Behavior; Health Care and Treatment; Health Testing and Trials; Communication Strategy; Health Industry
Milkman, Katherine L., John Beshears, James J. Choi, David Laibson, and Brigitte C. Madrian. "Planning Prompts as a Means of Increasing Preventive Screening Rates." Preventive Medicine 56, no. 1 (January 2013): 92–93.
- 15 Jan 2018
- News
A Better Business Model for Fighting Cancer
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- 07 Aug 2000
- Research & Ideas
Rocket Science Retailing
Retailers can significantly improve forecast accuracy simply by updating their predictions based on early sales data, tracking the accuracy of their forecasts, getting product testing right, and using a variety of forecasting approaches.... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
Kate Bingham (MBA 1991) Kate Bingham (MBA 1991) When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health Investors, the enormity of leading... View Details
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
October. However, when the drug testing panel includes a proportionate share of Black participants, doctors are much more willing to write a prescription. Black patients, in turn, were more likely to trust a medicine when clinical trials... View Details
- 18 Feb 2016
- News
Challenge Aims to Speed Drug Trials Process
The HBS Health Care Initiative is seeking innovative ideas from the science, patient, business, and medical communities on how to transform trials for precision medicine. Through the HBS Precision Trials Challenge, it aims to bring diagnostics and therapies to market... View Details
- 24 Apr 2014
- News
Finding a cure for cancer became a personal mission
Thai Lee (MBA 1985), president and CEO of SHI International, talks about how a family crisis led her to funding cancer research. (Published April 2014) View Details
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
- Article
Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials
By: Caroline Marra, William J. Gordon and Ariel Dora Stern
Objectives: In an effort to mitigate COVID-19 related challenges for clinical research, the U.S. Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in the use of... View Details
Keywords: Connected Digital Products; Telehealth; Remote Monitoring; Health Testing and Trials; Research; Governing Rules, Regulations, and Reforms; Information Technology
Marra, Caroline, William J. Gordon, and Ariel Dora Stern. "Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials." BMJ Open 11, no. 6 (2021).